Article
Mutational spectrum of the iduronate-2-sulfatase gene in Mexican patients with Hunter syndrome.
European review for medical and pharmacological sciences - 1 Jul 2022
Ramírez-Hernández M A, Figuera L E, Rizo-de la Torre L C, Mendoza-Ruvalcaba M T Magaña-Torres S C, Arnaud-López L, García-Ortiz J E, Zúñiga-González G M, Puebla-Pérez A M, Gómez-Meda B C, Gallegos-Arreola M P
Abstract excerpt
OBJECTIVE: Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is caused by deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS), which is responsible for degrading heparan and dermatan sulfate. The IDS gene is located on chromosome Xq28; pathological variants in this gene mostly consist of missense mutations and small and larger deletions, which produce different phenotypes. However, there is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
